COMPARATIVE ANALYSIS OF PAIN-RELATED QUALITY OF LIFE IN PATIENTS WITH LYMPHOMA AND BREAST CANCER
DOI:
https://doi.org/10.71000/az90n204Keywords:
Breast Neoplasms; Lymphoma; Neoplasm Pain; Quality of Life; Surveys and Questionnaires; Visual Analog ScaleAbstract
Background: Cancer-related pain remains one of the most distressing and disabling symptoms experienced by patients, significantly compromising quality of life (QoL). It may arise from tumor progression, treatment-related effects, or long-term complications, affecting physical, psychological, and social well-being. Both breast cancer and lymphoma patients commonly report moderate to severe pain, yet the extent to which pain influences QoL may differ between these malignancies due to variations in disease characteristics, treatment modalities, and systemic involvement.
Objective: To compare the impact of pain on quality of life among patients with breast cancer and lymphoma, with particular emphasis on differences in pain severity and associated functional outcomes.
Methods: A comparative cross-sectional study was conducted in government hospitals of Lahore over a six-month period. A total of 62 patients were enrolled through purposive sampling, including 31 breast cancer and 31 lymphoma patients. Adult patients with stages I–III disease experiencing moderate to severe pain were included. Pain intensity was assessed using the Visual Analogue Scale (VAS), while quality of life was evaluated using the SF-36 questionnaire. Data were analyzed using IBM SPSS, with descriptive statistics and chi-square tests applied to determine associations between pain severity and QoL.
Results: The mean age was 55.3 years in lymphoma patients and 52.6 years in breast cancer patients. The mean VAS score was 6.39 ± 1.38 for lymphoma and 6.65 ± 1.54 for breast cancer patients, with an overall mean of 6.52 ± 1.46. Poor and below-average QoL was reported in 58.7% of lymphoma patients and 80.7% of breast cancer patients. A statistically significant association between pain severity and QoL was observed in lymphoma patients (χ² = 12.45, p = 0.048), whereas no significant association was found in breast cancer patients (χ² = 9.83, p = 0.089).
Conclusion: Pain demonstrated a differential impact on quality of life across cancer types, with a stronger and significant association observed in lymphoma patients. These findings underscore the need for tailored pain management strategies to improve patient-centered outcomes in oncology care.
Keywords: Breast Neoplasms; Lymphoma; Neoplasm Pain; Quality of Life; Surveys and Questionnaires; Visual Analog Scale
References
Rebner M, Pai VR. Breast cancer screening recommendations: African American women are at a disadvantage. Journal of Breast Imaging. 2020;2(5):416-21.
Poço Gonçalves J, Veiga D, Araújo A. Chronic pain, functionality and quality of life in cancer survivors. British Journal of Pain. 2021;15(4):401-10.
Sullivan MJ, Mankovsky T. Chronic Pain, Types of (Cancer, Musculoskeletal, Pelvic), Management of. Encyclopedia of Behavioral Medicine: Springer; 2020. p. 453-9.
Zeller B, Loge JH, Kanellopoulos A, Hamre H, Wyller VB, Ruud E. Chronic fatigue in long-term survivors of childhood lymphomas and leukemia: persistence and associated clinical factors. Journal of pediatric hematology/oncology. 2014;36(6):438-44.
Muller M, Broséus J, Feugier P, Thieblemont C, Beaugerie L, Danese S, et al. Characteristics of lymphoma in patients with inflammatory bowel disease: a systematic review. Journal of Crohn's and Colitis. 2021;15(5):827-39.
Zimmaro LA, Carson JW, Olsen MK, Sanders LL, Keefe FJ, Porter LS. Greater mindfulness associated with lower pain, fatigue, and psychological distress in women with metastatic breast cancer. Psycho‐Oncology. 2020;29(2):263-70.
Faruk M. Breast cancer resistance to chemotherapy: When should we suspect it and how can we prevent it? Annals of Medicine and Surgery. 2021;70:102793.
Henriques B, Mendes F, Martins D. Immunotherapy in breast cancer: when, how, and what challenges? Biomedicines. 2021;9(11):1687.
Kolb R, Zhang W. Obesity and breast cancer: a case of inflamed adipose tissue. Cancers. 2020;12(6):1686.
Liu L, Hao X, Song Z, Zhi X, Zhang S, Zhang J. Correlation between family history and characteristics of breast cancer. Scientific reports. 2021;11(1):6360.
Wang L, Cohen JC, Devasenapathy N, Hong BY, Kheyson S, Lu D, et al. Prevalence and intensity of persistent post-surgical pain following breast cancer surgery: a systematic review and meta-analysis of observational studies. British journal of anaesthesia. 2020;125(3):346-57.
Gong Y, Tan Q, Qin Q, Wei C. Prevalence of postmastectomy pain syndrome and associated risk factors: A large single-institution cohort study. Medicine. 2020;99(20):e19834.
Suchodolska G, Senkus E. Mobile applications for early breast cancer chemotherapy-related symptoms reporting and management: A scoping review. Cancer Treatment Reviews. 2022;105:102364.
Solikhah S, Matahari R, Utami FP, Handayani L, Marwati TA. Breast cancer stigma among Indonesian women: a case study of breast cancer patients. BMC women's health. 2020;20:1-5.
Lewis WD, Lilly S, Jones KL. Lymphoma: diagnosis and treatment. American family physician. 2020;101(1):34-41.
de Leval L, Jaffe ES. Lymphoma classification. The Cancer Journal. 2020;26(3):176-85.
Thompson MA, Henderson JP, Shah PK, Rubinstein SM, Joyner MJ, Choueiri TK, et al. Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19. JAMA oncology. 2021;7(8):1167-75.
Booker R. Examining symptom burden and the palliative care needs of patients with hematologic malignancies. Victoria: University of Victoria. 2024.
Slotman E, Fransen HP, van Laarhoven HW, van den Beuken-van Everdingen MH, Tjan-Heijnen VC, Huijben AM, et al. Reduction in potentially inappropriate end-of-life hospital care for cancer patients during the COVID-19 pandemic: A retrospective population-based study. Palliative Medicine. 2024;38(1):140-9.
Lutgendorf SK, DeGeest K, Sung CY, Arevalo JM, Penedo F, Lucci III J, et al. Depression, social support, and beta-adrenergic transcription control in human ovarian cancer. Brain, behavior, and immunity. 2009;23(2):176-83.
Lovelace DL, McDaniel LR, Golden D. Long‐term effects of breast cancer surgery, treatment, and survivor care. Journal of midwifery & women's health. 2019;64(6):713-24.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Hira Tariq, Zohaib Shahid, Sarah Ahmad, Huma Idrees , Khadija Usman, Umera Iftikhar, Samara Shaukat (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
